Eyestem Research has completed the first set of patient injections for its RPE suspension therapy aimed at treating Dry age-related macular...

Dry AMD, a leading cause of vision loss in the ageing population of people over 50, has long been a challenge due to the limited availabili...

Advancements in new drug and stem cell therapy can transform the treatment of many diseases, but development is complicated, takes years an...

Geographic atrophy can lead to irreversible loss of vision over time and currently affects 200 million people globally.

Limitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.

Eyestem Research has announced the submission of IND application to CDSCO to start first in-human trials of Eyecyte-RPE™for subjects.

Eyestem has appointed Ravi Achar as Head- North America Strategy and also engaged Stradling Yocca Carlson & Rauth as its US law firm.

All roads lead to ET Startup Awards on 19 Nov. Union cabinet ministers Piyush Goyal and Ashwini Vaishnaw along with Karnataka chief ministe...

The awards were tightly contested, demonstrating a pipeline of innovation and enterprise that is steadily improving the economy's productiv...

This year’s meeting took place against the backdrop of widespread turmoil across public and private markets, which has slashed the valuatio...

Eyestem’s aim to treat “incurable” eye diseases helped it pip Haber, an artificial intelligence powered startup that simplifies manufacturi...

The award will recognise innovations that launch a business or give it a big boost. It should be an original idea that is core to the busin...

C-CAMP is one of the largest biotech ecosystems in India and a global hub for innovations led by deep-tech.

The investment will enable Eyestem to progress a treatment for Dry Age-related Macular Degeneration to the clinic.

Existing investors Endiya Partners and Kotak Private Equity also participated in this round, valuing Eyestem at $46.4 million (INR 371 Cror...

Cell and gene therapy can go a long way in treating incurable diseases, but currently it is very pricey. Eyestem wants to dramatically cut ...

A new set of deep science startups is delving into subjects as diverse as medicine, energy and agri to lay the foundation for a large biote...